I-neurobiology yezokugembula kokugula kanye nokulutha kwezidakamizwa ukubuka konke kanye nokuthola okusha (2008)

 

I-Philos Trans R Soc Lond B Biol Sci. I-2008 Okthoba 12; 363(1507): 3181-3189.

Ishicilelwe online 2008 Julayi 18. doi:  10.1098 / rstb.2008.0100

abstract

Ukugembula kuwukuziphatha okuvamile kokuzijabulisa. Cishe i-5% yabantu abadala ilinganiselwa ukuthi ibhekana nezinkinga ngokugembula. Uhlobo olunzima kakhulu lokugembula, ukugembula kwe-pathological (PG), lubonwa njengesimo sempilo yengqondo. Imibono emibili ehlukile engaguquki ekhethekile ye-PG ikubheke njengokuphazamiseka okubonakalayo kokungabonakali komlutha nokulutha 'ngokuziphatha'. Ukuqondisisa okufanele kwe-PG kunemithelela ebalulekile ngokomqondo nakusebenzayo. Idatha iphakamisa ubuhlobo obusondelene phakathi kwe-PG nokuphazamiseka kokusetshenziswa kwezidakamizwa kunokukhona phakathi kwe-PG kanye ne-obsessive-activive disorder. Leli phepha lizobuyekeza imininingwane kwi-neurobiology ye-PG, libheke ukuqondwa kwayo njengokulutha kokuziphatha, lixoxe ngokufakelwa njengokwakhiwa okuyisisekelo, futhi liveze okutholakele kokucabanga kobuchopho okusha okuphenya ukufakwa kwe-neural kwezindawo ezinxanele i-PG uma kuqhathaniswa nalezo ezixhomekeke ekuthembekeni kwe-cocaine. Imiphumela yezindlela zokuvimbela nokwelashwa izodingidwa.

Amagama angukhiye: ukugembula, umlutha, ukufakwa kokulawula, ukuthikameza kokulawula okuphathelene nomqondo, ukucabanga kobuchopho, ukucabanga kobuhlakani obusebenzayo

I-1. Ukuzijabulisa, inkinga kanye nokugembula kwe-pathological

Ukugembula kungachazwa njengokubeka okuthile kwenani engcupheni ethembeni lokuthola okuthile kwenani elikhulu kakhulu (Potenza 2006). Iningi labantu abadala liyabheja, futhi iningi lenza kanjalo ngaphandle kokuhlangabezana nezinkinga ezinkulu. Noma kunjalo, izinkinga zokugembula phakathi kwabantu abadala ziye zalinganiselwa ukuthi ziphezulu njenge-5%, namaqembu athile (abantu abadala abancane, abantu abanenkinga yempilo yengqondo nabantu ababoshiwe) abanokulinganisa okuphindwe kabili okuphezulu (Shaffer et al. 1999). Ukugembula kwe-Pathological (PG), okufanekisela uhlobo olubi kakhulu lokugembula okuyinkinga (bheka ngezansi), kulinganiselwa kokuqagela cishe kwe-0.5-1% (UPretty et al. 2005). Njengoba kunikezwe ukutholakala okwengeziwe kokugembula okusemthethweni nokuthandwa kwaso emashumini amaningi eminyaka adlule, ukunakwa okuthe xaxa emiphumeleni yezempilo yamazinga athile wokuziphatha kokugembula kufanelekile (UShaffer noKorn 2002).

Kwakungenxa kuze 1980 ukuthi Diagnostic futhi ibhukwana incwajana (DSM) ichaza indlela yokuphazamiseka kokugembula (I-American Psychiatric Association 1980). Igama elithi 'PG' lakhethwa ukuze lisebenzise amanye amagama (isib. Ukugembula okuphoqayo) okwakusetshenziswa kabanzi ngaleso sikhathi, mhlawumbe emzameni wokuhlukanisa lo mqedazwe kokungaboni ngasolinye. Kanye ne-pyromania, i-kleptomania, i-trichotillomania kanye nezifo eziqhumayo eziqhubekayo, i-PG njengamanje ihlukaniswa ngokuthi 'i-impulse control disorder (ICD) hhayi kwenye indawo' kwi-DSM. Ngokufanayo, ku-International Classization of Disways, lesi sifo sihlukaniswa ngaphansi kwe- 'Habit and impulse disrupt' kanye ne-pyromania, kleptomania kanye ne-trichotillomania. Izindlela eziningi zokuxilonga yamanje zezici zokwabelana ze-PG nalezo zokuncika kwezidakamizwa (DD). Isibonelo, izindlela eziqondise ukubekezelela, ukuhoxa, imizamo ephindaphindayo engaphumelelanga yokunciphisa noma ukuyeka, kanye nokuphazamiseka ezindaweni ezinkulu zokusebenza kwempilo kuqukethe imibandela ye-PG ne-DD. Ukufana kunwebeka kwizizinda ezingama-phenomenological, epidemiological, clinical, genetic kanye nezinye izizinda zezinto eziphilayo (Goudriaan et al. 2004; Potenza 2006; IBrewer & Potenza 2008), kuphakamisa imibuzo yokuthi ingabe i-PG ingahle ibonwe njengomlutha 'wokuziphatha'.

I-2. I-PG njengomlutha

Uma i-PG imele umlutha, kufanele yabelane ngezici eziyinhloko ze-DD. Izingxenye eziyinhloko zokulutha ziye zahlongozwa kufaka (i) ukuqhubeka kokuzibandakanya ekuziphatheni yize kunemiphumela emibi, (ii) kwehlise ukuzithiba ngokuzibandakanya ekuziphatheni, (iii) ukuzibandakanya okuphoqelekile ekuziphatheni, kanye (iv) nokunxenxa okujabulisayo noma Ukufuna izwe ngaphambi kokuzibandakanya ekuziphatheni (Potenza 2006). Eziningi zalezi zici, kanye nezinye, njengokubekezelela nokuhoxisa, zibonakala zilungele i-PG ne-DD (Potenza 2006). Izifundo ezifanayo ze-PG ne-DD kufanele zisize ukuchaza izici ezihlobene nezidakamizwa. Okusho ukuthi, izidakamizwa zingathonya ukwakheka kobuchopho futhi zisebenze ngezindlela eziphakathi nendawo noma ezingahambisani nenqubo yokulutha. Ngaleyo ndlela i-PG ingacatshangwa njengomlutha ngaphandle komuthi, ukuqhathanisa okuqondile kwalezi zinkinga kunganikeza ukuqonda kwezici ezingumgogodla zomlutha wokulutha futhi kuqondise ukuthuthukiswa nokuhlolwa kokwelashwa okusebenzayo.

I-3. Izinhlelo ze-Neurotransmitter ne-PG

Ama-neurotransmitters acacisiwe ahanjisiwe ukuthi ahlobane nezici ezihlukile ze-PG. Ngokusekelwe ocwaningweni lwe-PG kanye / noma okunye ukuphazamiseka, i-noradrenaline ifakwe ama-ICD ukuthi ibhekane ngqo nezici zokuvuselela injabulo, i-serotonin ekuqalisweni kokuziphatha kanye nokuyeka, i-dopamine ukuvuza nokuqinisa, kanye ne-opioids yokujabulisa noma ukunxusa. Lezi nezinye izinhlelo zibhekwa ngezansi.

(a) INoradrenaline

Ucwaningo olwenziwe phakathi kwama-1980s luqhathanisa abesilisa ne-PG kulabo ngaphandle futhi bathola amazinga aphezulu e-noradrenaline noma ama-metabolites awo omchamo, igazi noma amasampula we-cerebrospinal fluid kulowo owedlule (Roy et al. 1988), nezinyathelo ze-noradrenergic ezihlotshaniswa nezinyathelo zokuguqula (Roy et al. 1989). Ukugembula noma indlela yokuziphatha ehlobene nayo kuhlotshaniswe ne-autonomic arousal, ne-pachinko play kanye ne-casino blackjack ngayinye ehlotshaniswa nokuphakama kwenhliziyo nokwenyuka kwezinyathelo ze-noradrenergic (Shinohara et al. 1999; Meyer et al. 2000). Ngesikhathi sokugembula kwamakhasino we-casino, izinga lokushaya kwenhliziyo nezinyathelo ze-noradrenergic ziphakanyiselwa ngezinga elikhulu emadodeni anezinkinga zokugembula ngokuqhathaniswa nalawo angenawo (Meyer et al. 2004). Ngaphezu kwendima engenzeka ekuvuseleleni noma ekujabuliseni, i-Noradrenaline ingahle ihlobane nezinye izici ze-PG. Isibonelo, umsebenzi we-noradrenergic uthonya ukusebenza kwangaphambi kokuqala kwe-cortical ne-posterior ukunakwa kokunakekelwa, nemithi (isib. I-noradrenaline transport inhibitor atomoxetine kanye ne-alpha-2 adrenergic agonists clonidine ne-guanfacine) esebenza ngamasu we-adrenergic aboniswe ukuthi asebenza kahle ekwelashweni kokunaka. -deficit hyperacaction disorder kanye nezinye izifo zengqondo (I-Arnsten 2006). Izidakamizwa ze-Adrenergic zikhonjisiwe ukuthi zithonye izici ezithile zokulawulwa okungathandeki ezifundweni zezilwane nezabantu (IChamberlain neSahakian 2007). Lokhu okutholakele kusikisela izindima eziningana ezingenzeka zomsebenzi we-adrenergic ku-PG kanye nokwelashwa kwaso, futhi olunye uphenyo luyadingeka kule ndawo ukuhlola lokhu okungenzeka.

(b) ISerotonin

Ngokwesiko, ukusebenza kwe-serotonin kuye kwabhekwa njengokubaluleke kakhulu ekulameni ukulawulwa kokungathandeki. Abantu abanamazinga afanele wokulawulwa kokuthinteka kokuphazamiseka, kubandakanya nalabo abane-PG (INordin & Eklundh 1999) noma ulaka olungaphenduki (ULinnoila et al. 1983), bakhombise amazinga aphansi we-serotonin metabolite 5-hydroxy indoleacetic acid. Abantu abane-PG noma okunye ukuphazamiseka noma isimilo esibonakaliswa ukulawulwa kokungafaneleki kokuphazamiseka (isib. Ulaka olungahambi kahle) babonisa izimpendulo ezihlukile zokuziphatha nezokuthakazelela izidakamizwa ze-serotonergic kunokwenza izifundo zokulawula okunempilo. Abantu abane-PG babike ukuphathwa okulandelayo okuphezulu meta-chlorophenylpiperazine (m-CPP), i-agonist eyisisekelo ye-serotonin enamathela kuma-5HT amaningi1 no-5HT2 ama-receptors anokuxhumana okuphezulu kakhulu kwe-5HT2c receptor (I-DeCaria et al. 1998; Pallanti et al. 2006). Le mpendulo yayiqhathaniswa nalena yezifundo zokulawula futhi yayifana nezilinganiso eziphakeme ezazibikwa ngaphambili ngabaphikisi bezinhlangano, umngcele kanye nezihloko zotshwala ngemuva kokuthola umuthi. Impendulo ye-Prolactin ku-m-CPP ibuye ihlukanise i-PG kanye namaqembu okulawula, nokuphakama okukhulu kubonwe kokuqala.

I-Serotonergic probes isetshenziswe ngokuhlangana nokucabanga kobuchopho kubantu abanokulawulwa kokuthinteka kokuphazamiseka. Kubantu abanolaka oluxakile njengoba luqhathaniswa nolungaphandle, impendulo engenaphutha ku-cortex (vmPFC) ebonakalayo ibonakala iphendula i-m-CPP (New et al. 2002) noma i-agonist fenfluramine engaqondileUmthungi et al. 1999), ehambisanayo nokutholakele kwezidakwa (Indoda et al. 1997). Ucwaningo olufanayo alwenziwe kuze kube manje ku-PG, yize olunye uphenyo lube nomthelela emsebenzini we-vmPFC ku-PG (bheka ngezansi).

Njengoba kunikezwe idatha ephakamisa indima ebalulekile yokusebenza kwe-serotonin ku-PG kanye nokuphoqelela i-dyscontrol, izidakamizwa ze-serotonergic ziphenywe ekwelashweni kwe-PG (I-Brewer et al. 2008). I-Serotonin reuptake inhibitors ibonisa imiphumela exubile. Esilinganisweni esisodwa esincane, esilawulwa i-placebo, esilawulwa izimpumputhe kabili, se-crosasco ye-fluvoxamine, izingalo ezisebenzayo neze-placebo zahlukaniswa kakhulu phakathi kwengxenye yesibili yokuqulwa kwecala, izidakamizwa ezisebenzayo ezaziphakeme kune-placebo (Hollander et al. 2000). Isivivinyo esincane esilawulwa yi-placebo esincane asibonanga mehluko phakathi kwe-fluvoxamine esebenzayo ne-placebo (Mhlophe et al. 2002). Ngokufanayo, ukucwaninga okukodwa okungahleliwe, okulawulwayo, nokungaboni kabili kwe-paroxetine kukhombisile ukuphakama kwezidakamizwa ezisebenzayo ngaphezu kwe-placebo (Kim et al. 2002), kanti ucwaningo olukhulu, oluyindawo ephakathi nendawo, olawulwa ngokungahleliwe, olawulwa nge-placebo, olungaboni ngamehlo aluthole umehluko obalulekile phakathi kwezidakamizwa ezisebenzayo ne-placebo (Grant et al. 2003). Lezi zivivinyo zokuqala zivame ukungafaki abantu abanezifo zengqondo ezenzeka ndawonye. Isilingo esincane, esilebula elivulekile le-escitalopram elandelwa ukunqanyulwa okungaboni okubili senziwa kubantu abane-PG kanye nokuphazamiseka okubakhona kokukhathazeka (Isibonelelo & Potenza 2006). Ngesikhathi sesigaba esilebula evulekile, izindlela zokugembula nezokukhathazeka zithuthuke ngendlela efanayo. Ukwenza okungajwayelekile ku-placebo kuhlotshaniswa nokuqala kabusha kwezindlela zokugembula nezokukhathazeka, kanti ukwenza okungahleliwe kusidakamizwa esisebenzayo kuhlotshaniswa nezimpendulo eziqhubekayo. Yize kuqala, lokhu okutholakele kusikisela ukuthi umehluko obalulekile wabantu abathile ukhona phakathi kwabantu abane-PG, nokuthi umehluko unemiphumela ebalulekile ekuphenduleni kokulashwa.

(c) Dopamine

I-Dopamine ifakwa amandla ekuzuzeni nasekuqiniseni izimilo nasekuluthweni kwezidakamizwa (I-Nestler 2004). Kodwa-ke, zimbalwa izifundo eziphenye ngokuqondile indima ye-dopamine ku-PG. Kutholwe imiphumela ephikisayo yezinyathelo zokuphuza kwe-cerebrospinal fluid dopamine kanye nama-metabolites ayo ku-PG (Bergh et al. 1997; INordin & Eklundh 1999). Ngokufanayo, isifundo esisodwa sofuzo sokuqala se-PG saba nomthelela ekulimaleni kweTaqA1 yohlobo lwe-dopamine receptor gene DRD2 ngokufanayo kwi-PG, ukusetshenziswa kwezidakamizwa nokunye ukuphazamiseka kwengqondo (I-Comings 1998). Izifundo zakudala zofuzo lwe-PG zazivame ukufaka imikhawulo yendlela efana nokuntuleka kwehlukaniso lobuhlanga noma ubuzwe nokuhlolwa okungaphelele kokuxilongwa, kanye nezifundo ezalandela ezisebenzisa izindlela ezilawula ubuhlanga / ubuzwe kanye nokuthola ukuxilongwa kwe-DSM-IV azange zibone umehluko ekuvezweni kwe-TaqA1 frequency ku-PG (da Silva Lobo et al. 2007). Izincwadi ezibuyekezwe ontanga ezibandakanya izifundo ze-PG kanye nokuphenya izinhlelo ze-dopamine (noma ezinye) zisebenzisa izindlela ezisetshenzisiwe ze-ligand azikho, futhi izifundo ezinjalo zibonisa indawo ebalulekile yophenyo oluzayo.

Ama-PG namanye ama-ICD abonwe kubantu abanesifo sikaParkinson's (PD), isifo esibonakala ngokuwohloka kwe-dopamine nezinye izinhlelo (UJellinger 1991; amandla et al. 2007). Abantu abane-PD baphathwa ngezidakamizwa ezikhuthaza ukusebenza kwe-dopamine (isib. Levodopa noma i-dopamine agonists, ezifana ne-pramipexole noma i-ropinirole) noma ukungenelela (isib. Ukukhuthaza ubuchopho obujulile) okuthuthukisa i-neurotransuction ngokusebenzisa amasekethe ahlobene (I-Lang & Obeso 2004). Njengoba kunje, ama-ICD ku-PD angakwazi ukuphuma ku-pathophysiology yokuphazamiseka, ukwelashwa kwayo, noma inhlanganisela ethile yalokho. Izifundo ezimbili zaphenya ama-ICD kubantu abangamakhulu amaningana abane-PD (I-Voon et al. 2006; Weintraub et al. 2006). Ama-ICD ahlotshaniswa nesigaba sama-dopamine agonists esikhundleni sama-ejenti athile, futhi abantu abane-ICD babemncane futhi babeneminyaka yobudala ekuqaleni kwePD. Abantu abane-ICD futhi abangenawo ama-ICD nabo bayehluka kwezinye izinto ezihlobene nokulawulwa kokuthinteka kokuphazamiseka. Kokunye ukuhlola, labo abane-ICD kungenzeka ukuthi babe ne-ICD ngaphambi kokuqala kwe-PD (Weintraub et al. 2006). Kokunye, izifundo ze-PD ngaphandle nangaphandle kwe-PG zihlukaniswe ngezinyathelo zokuphoqelela, ukufuna izinto ezintsha kanye nophuzo oludakayo noma lwamalungu omndeni (I-Voon et al. 2007). Umthelela ongaba khona walokhu neminye umehluko oguquguqukayo uqinisekisa ukuthi kucatshangelwa ukuphenywa kwama-pathophysiologies kanye nokwelashwa kwama-ICD ku-PD. Yize uchungechunge lwe-anecdotal ne-cort lubika ukuphuculwa kwe-ICD Symbomatology ngokunqanyulwa noma ukuncipha kwe-dosing yama-dopamine agonists (UMamikonyan et al. 2008), lezi zifundo zingokwendalo ngokwemvelo futhi zingaphansi kokucatshangelwa okujwayelekile kwezivivinyo ezingalawulwa. Ngaphezu kwalokho, ezinye iziguli zingahle zingabekezeleli imithamo ephezulu ye-levodopa esetshenziselwa ukulawula izimpawu ze-PD kanti ezinye zingahlukumeza le mishanguzo (IGiovannoni et al. 2000; Evans et al. 2005). Ngokubambisana, lokhu okutholakele kukhombisa ukuthi ucwaningo olwengeziwe luyadingeka kuma-pathophysiologies kanye nokwelashwa kwama-ICD ku-PD.

(d) Ama-opioids

Ama-opioid afakwe umfutho ezinhlelweni ezijabulisayo nezinomvuzo, futhi ukusebenza kwe-opioid kungathonya i-neurotransuction emgudwini we-mesolimbic osuka endaweni ephakathi nendawo ye-chapral kuya ku-nucleus accumbens noma i-ventral striatum (Spanagel et al. 1992). Ngokwesisekelo yalokhu okutholakele kanye nokufana phakathi kwe-PG nokulutha, njengokuncika kotshwala, abamelene ne-opioid bahlolwe ekwelashweni kwe-PG namanye ama-ICD. Izilingo ezilawulwa i-placebo-blind-blind, blinded, ziye zahlola ukusebenza nokubekezela kwe-naltrexone ne-nalmefene. Umthamo omkhulu we-naltrexone (isilinganiso sokugcina sedosi yokufunda = 188mgd-1; finyelela ku-250mgd-1) wayephezulu kune-placebo ekwelapheni i-PG (Kim et al. 2001). Njengokuncika kotshwala, umuthi wabonakala ulusizo ikakhulukazi kubantu abanezifiso eziqinile zokugembula ekuqaleni kokwelashwa. Kodwa-ke, ukuhlukunyezwa kokuqina kwesibindi kwabonwa ngaphezulu kwe-20% yezifundo ezithola izidakamizwa ezisebenzayo ngesikhathi secala elifushane. INkosifene, umphikisi we-opioid ongahambisani nokukhubazeka kokusebenza kwesibindi, wahlolwa kamuva (Grant et al. 2006). INkosifene yayiphezulu kune-placebo, kanti ukuhlolwa kokusebenza kwesibindi akubhekwanga. Umthamo obonisa ukusebenza kahle kakhulu kanye nokubekezelela bekuyi-25mgd-1 umthamo, owodwa olingana cishe ne-50mgd-1 umthamo uvame ukusetshenziswa ekwelapheni utshwala noma ukuxhomekeka kwe-opiate. Ukuhlaziywa okwalandela komphumela wokwelashwa ku-PG ethola abaphikisi be-opioid kwakhomba umlando womndeni wokudakwa kotshwala njengento ehlotshaniswa kakhulu nokuphendula okuhle kwezidakamizwa, ukutholakala okuhambisana nezincwadi zotshwala (Grant et al. 2008). Izinga ezinye izinto ezihambisana nokuphendula ngalo ukwelashwa kubaphikisi bezidakamizwa e-opioid (isb. Ukwahlukahluka kofuzo okufaka i-μ-opioid receptor; Oslin et al. 2003) ukunweba ekwelashweni kwe-PG warwedates uphenyo oluqondile.

(e) I-Glutamate

I-Glutamate, i-neurotransmitter ejabulisa kakhulu, ifakwe umfutho ezinqubekweni ezishukumisayo nasekuluthweni kwezidakamizwa (Chambers et al. 2003; IKalivas neVolkow 2005). Kususelwa kule mininingwane nokutholwe kuqala okubonisa indima yemithi yokwelapha i-glutamatergic kwamanye ama-ICD (I-Coric et al. 2007), umenzeli wokumodareyitha we-glutamatergic N-acetyl cysteine ​​yaphenywa ekwelashweni kwe-PG (Grant et al. 2007). Idizayini yocwaningo ifaka ukwelashwa okulebula ngokuvuleleka okulandelwa ukuyekiswa okungaboni okubili. Ngesikhathi sesigaba esilebula evulekile, i-Symbomatology yokugembula yathuthuka kakhulu. Ukulandela ukuhlukaniswa okungaboni okubili, ukuthuthukiswa kugcinwe ku-83% yabaphenduli enziwe waba nomqondo ongemuhle ku-izidakamizwa ezisebenzayo ngokuqhathaniswa ne-29% yalabo abenziwe nge-placebo. Le mininingwane yokuqala ibonakalisa isidingo sophenyo olwengeziwe ngeminikelo ye-glutamatergic ku-PG nokwelashwa kwe-glutamatergic ekwelashweni kwayo.

I-4. Izinhlelo ze-Neural

Abaphenyi abambalwa bahlolisisa ukuthi imisebenzi yobuchopho ihluke kanjani kubantu abane-PG noma amanye ama-ICD ngokuqhathaniswa nalawo angenayo. Ucwaningo olulodwa olusebenzayo lokuqala lwe-magnetic resonance imaging (fMRI) luphenye ukunxenxa noma ukuthanda izifundazwe emadodeni ane-PG (amandla et al. 2003b). Lapho ubheka amateyipu wokugembula nangaphambi kokuqala kokuphendula okuphathelene nokushukumisela noma ngokomzwelo, abagembuli be-pathological (PGers) njengoba kuqhathaniswa nabokuzithokozisa bakhombisa ushintsho oluncane lwe-oxygen oxygen-based (BOLD) changes in frontal cortical, basal ganglionic and thalamic brain region . Lokhu umehluko phakathi kweqembu akubonwanga ngesikhathi sevidiyo ejabulile noma edabukisayo ngesikhathi sokuqhathanisa sokubuka, futhi okutholakele kuhlukile ezifundweni zabantu abanokuphazamiseka kwengqondo okubonakalayo, okuvame ukukhombisa ukwenziwa okuthe xaxa kwalezi zifunda phakathi kwezifundo zokuvusa izimpawu. (UBreiter noRauch 1996). Ngesikhathi sokugcina sokubuka i-tepi, isikhathi lapho kwethulwa khona okokukhuthaza ukugembula okunamandla kunabo bonke, amadoda ane-PG ngokuqhathaniswa nalawo ngaphandle ayephawuleka kakhulu ngokukhombisa ushintsho lwesiginali BOLD olwehlisiwe ku-vmPFC. Lokhu okutholakele kubonakala kuhambisana nalokho okuvela kwizifundo zokulawulwa kokuthinteka kokuphazamiseka kwezinye izizinda zokuziphatha, ubuhlakani obukhulu (Umthungi et al. 1999; New et al. 2002) nokwenza izinqumo (Bechara 2003).

Yize ezinye izifundo zokucabanga zinethonya lesifunda sangaphambili kwi-PG (ICrockford et al. 2005), uphenyo oluningi lubonile umehluko ekusebenzeni kwe-vmPFC ku-PG. Ucwaningo lokulawula kwengqondo kusetshenziswa uhlobo oluhlobene nomcimbi wokuphazanyiswa kombala we-Stroop bathola ukuthi amadoda ane-PG ngokuqhathaniswa nalawo ngaphandle ahlukaniswe kakhulu ngokushintshwa kwesiginali BOLD okunciphisiwe ku-vmPFC kwesokunxele kulandela ukwethulwa kwesimangalo esingalungileamandla et al. 2003a). Lapho benza okufanayo kwe-fMRI Stroop paradigm, abantu abanenkinga yokuphefumula babehlukaniswa kakhulu kwizifundo zokulawula esifundeni esifanayo se-vmPFC (Blumberg et al. 2003), kuphakamisa ukuthi ezinye izinto ezivamile kokuphazamiseka (isib. ukulawulwa kokungafaneleki kokuphathwa, ukulawulwa okungokomzwelo okungalungile) zabelana ngezakhi zomhlaba ezingaphansi kwemingcele yokuxilonga. Nge-analog, abantu abathembele kwinto noma ngaphandle kwe-PG bakhombise ukwenziwa okuncane kwe-vmPFC kunokulawula izihloko ekuhlolweni kokuthatha izinqumo 'zokugembula' (UTanabe et al. 2007).

Kokunye ukuhlola kwe-fMRI, abantu abane-PG njengoba kuqhathaniswa nalabo ngaphandle kokukhombisa ukusebenza kancane kwe-vmPFC ngesikhathi sokugembula okulinganiselwe kuqhathaniswa nokuwina nokulahlekelwa kwezimo, futhi ukuguqulwa kwesiginali BOLD ku-vmPFC kuhlobene nobunzima bokugembula phakathi kwe-PGers (Ukubuyela emuva et al. 2005). Esifundweni esifanayo nokusebenzisa umehluko ofanayo, iphethini efanayo yokuncishiswa kwehle yabonwa kwabakwa-PG endaweni ye-ventral striatum, indawo yobuchopho ene-dopaminergic innervation futhi okunomthelela omkhulu ekuluthweni kwezidakamizwa nasekusebenziseni umvuzo (I-Everitt neRobbins 2005). Kususelwa emsebenzini ezinsukwini zokuqala (Schultz et al. 2000), izifundo zokulungiswa kwemivuzo kubantu zihlobanise ukusebenza kwe-ventral striatum ngokulindela ukusebenza komvuzo wemali nokwenza kusebenze i-vmPFC ngokuthola imivuzo yemali (Knutson et al. 2003). Lo mjikelezo ubonakala usebenza kakhulu ekucutshungweni kwemivuzo masisha njengoba ukukhethwa komvuzo obambezelayo obukhulu kubandakanya amanethiwekhi e-dortal cortical network (McClure et al. 2004). Ukugembula kweBlackjack njengoba kuqhathaniswa nokudlala i-blackjack yamaphoyinti kuhlotshaniswa nokwenza okwengeziwe kwe-corticostriatal ku-PGers (Hollander et al. 2005). Kodwa-ke, lolu cwaningo aluzange lufake izifundo ezingenayo i-PG ngakho-ke aluzange luphenye ukuthi izifundo ze-PG ziyehluka kanjani kulabo abangenawo lo mkhuba. Ukutholwa kokusebenza okuncishisiwe kwe-cyral striatum ku-PGers ku-paradigm yokugembula eyenziweUkubuyela emuva et al. 2005) iyahambisana nokutholakele kusuka ocwaningweni lokulindelwa komvuzo kubantu abanokulutha noma okubonakala sengathi kusengozini yalokhu kuphazamiseka. Isibonelo, ukwenziwa okunciphise kokusebenza kwe-ventral striatum ngesikhathi sokulindelwa kwemivuzo yemali kuye kwabikwa kubantu abethembele otshwaleni (IHommer 2004; Sula et al. 2007) noma ukuxhomekeka kwe-cocaine (CD; Pearlson et al. 2007) kanye nasebusheni ngokuqhathaniswa nabantu abadala (I-Bjork et al. 2004) nalabo abanomlando womndeni wotshwala ngokuqhathaniswa nalezo ezingenawo (Indoda et al. 2004). Ngokubambisana, lokhu okutholakele kusikisela ukuthi ukwenziwa okuncishisiwe kokusebenza kwe-ventral striatum ngesikhathi sokulindela kokulungiswa kwemivuzo kungahle kumelele phenotype ebalulekile yomlutha wezidakamizwa nama-ICD.

I-5. Isifiso sokuncenga esijwayelekile ku-PG naku-CD

Isifiso esivumayo noma izifiso ezifisayo ngokuvamile zandulela ukubandakanyeka ekuziphatheni okuyinkinga njengokugembula kwabakwa-PGers noma ukusetshenziswa kwezidakamizwa ekuluthweni kwezidakamizwa. Kanjalo, ukuqonda kokuhlangana kwe-neural yalezi zifundazwe kunomthelela obalulekile emtholampilo (izindleko et al. 2006). Ngokombono wesayensi, ucwaningo lwezinqubo ezifanayo, njengokuthi izifiso ezinxanelekayo kubantu abane-PG noma labo abane-DD, zingacacisa izici eziwumgogodla wenqubekelaphambili yezinqubo ezishukumisayo kuzo zonke iziphazamiso, ngaphandle kwemiphumela yokuvezwa kwezidakamizwa okubi kakhulu noma okungamahlalakhona.

Ukuphenya, sisebenzise idatha kwizifundo zethu ezishicilelwe zezinhlelo zokugembula ku-PG (amandla et al. 2003b) nokunxanela izidakamizwa kwi-CD (Wexler et al. 2001). Njengoba ucwaningo lwethu lokugembula luhilela izifundo zabesilisa kuphela, sinqande ukucubungula emadodeni, siveza isampula kufaka phakathi izifundo ze-10 PG kanye nokugembula kwe-11 (CPG izikhonzi) ababuke amageyipu wokugembula, odabukisayo futhi ajabule ngesikhathi se-fMRI, nezifundo ze-9 CD kanye nabalingisi be-non-cocaine abasebenzisa iCocaine (CCD izikhonzi) ababuke i-cocaine, izimo ezidabukisayo nezinenjabulo, njengoba kuchaziwe ngaphambili. Siphenye ngale ndlela elandelanayo ukuthi ubungakanani bokusebenza kobuchopho ekusebenzeni okushukumisayo noma ngokomzwelo buyefana noma buhluke kumlutha wokuziphatha onjenge-PG uma uqhathanisa ne-CD yokulutha kwezidakamizwa. Siphinde sazi ukuthi izifunda zobuchopho obumsebenzi wazo obuthonywe yi-cocaine exposition, ezifana ne-cortex yangaphambili ne-anterior cortex, buzohileleka ngokwahlukahlukana kwezifiso ze-cocaine ezise-CD nasezincekelweni zokugembula ku-PG.

Sisebenzise inqubo esekwe nge-voxel ukwazisa ukubaluleka kwezibalo esizukulwaneni se pAmamephu akhomba umehluko ngendlela ukusebenza kobuchopho bezihloko ezithintekile okwehlukile ngayo kwezilawuli kuwo wonke amaqembu okugembula necocaine ngesikhathi sokubukwa komlutha, amateyipu evidiyo ajabule futhi adabukisayo (Wexler et al. 2001; amandla et al. 2003b). Eqenjini ngalinye lezihloko ezibuka uhlobo ngalunye lwetheyiphu, sikhiqize a t-map ngokuqhathanisa isikhathi sokubuka kwesimo njengoba kuqhathaniswa nemigwaqo eyisisekelo yesibuko se-pre-and post-tape grey screen. Okulandelayo, zohlobo ngalunye lwetheyiphu, esikhiqizayo t-Imisho lokwehlukanisa umehluko lapho tifundvo letitsintekile (sibonelo i-PG) leyehluka kulawulo lwato lolutsite (sib. CPG), yakha i-PG-CPG umehluko. Okulandelayo, siqhathanisa indlela amaqembu athintekayo ahluke ngayo kulawulo kuyo yonke imilutha ((PG-C.)PG) - (CD-CCD); ithebula le-1a, bona isibalo 1A kokuqukethwe kokungezelelwa ngogesi). At p<0.005 nokusebenzisa iqoqo lama-25 ukukhulisa i-stringency (UFriston et al. 1994), umehluko ohlobene nokuphazamiseka kokungafani phakathi kwamaqembu athintekayo nawathintekile athintekayo abonwa ngesikhathi kubhekwa ompompi bokulutha (ithebula le-1a; bona i-figure 1A kokuqukethwe kokungezelwa kwe-elekthronikhi) kepha hhayi izimo ezidabukisayo noma ezijabulisayo (ezingakhonjiswanga). Izifunda ze-ventral kanye ne-dorsal anterior cingulate kanye ne-parietal lobule ephansi efanelekile zikhonjwe ngenkathi kubukwa lezi zimo zokulutha, ngomsebenzi omncane oye wehla ku- (PG-CPG) qhathanisa ngokuqhathaniswa ne- (CD-CCD) ukuqhathanisa. Iminikelo yeqembu engaphansi kwesifundo kulokhu umehluko iyabhalwa (ithebula le-1a). I-cortex ye-anterior, isifunda sobuchopho esifakwe ekucutshungulweni ngokomzwelo nokulawula kokuqonda kokuphilile (Bush et al. 2000) nezihloko ze-CD (IGoldstein et al. 2007), kukhonjiswe ukuthi kusebenze ngenkathi kunxenxa i-cocaine (Izingane et al. 1999). Ukuphathwa kwe-Cocaine kusebenze i-cingulate engaphandle (Febo et al. 2005), nesikhathi kanye nephethini yokuphatha i-cocaine kunomthelela emsebenzini we-cingate we-anterior (IHarvey 2004). Umehluko ekusebenzeni okungaphansi kwe-parietal lobule kumaqembu ezifundo kukhombisa umehluko omkhulu ezimpendulweni ze-neural zamaqembu olawulo emidlalweni yokugembula neyama-cocaine. I-parietal lobule engaphansi iye yafakwa umthelela ekuphenduleni kwezakhi zokuvimbela zomthethonqubo wethonya (I-Menon et al. 2001; Igalari et al. 2006). Ngakho-ke, okutholakele kukhombisa ukuthi amateyipu wokubuka wokuqukethwe okuhlukile (isb. Izincazelo zokuziphatha okungahlangene nomphakathi (ukugembula) ngokuqhathaniswa nomsebenzi ongekho emthethweni (ukusetshenziswa kwe-cocaine)) kuhlotshaniswa nokwenza kusebenze okuhlukile kulawulo lwezifundo zesifunda sobuchopho ezibandakanyekayo ekuphenduleni kokulamula ukuvimbela.

Ithebula 1

Ukusebenza kobuchopho ku-PG ne-CD kuqhathaniswa nezifundo zokulawula.

Sibe sesiphenya izifunda zobuchopho ezivame ukufiswa yizifiso ze-cocaine nezifiso zokugembula, sibonisa ukuthi sizokhomba izindawo zobuchopho ezibe nomthelela ofanayo kwi-CD naku-PG, njengokuncipha kokusebenza kwe-ventral striatum ekusebenzeni kwemivuzo ethintekayo kuqhathaniswa nezihloko zokulawula (Ukubuyela emuva et al. 2005; Pearlson et al. 2007). Eqenjini ngalinye lezihloko ezibuka uhlobo ngalunye lwetheyiphu, sikhiqize a t-map ngokuqhathanisa isikhathi sokubuka kwesimo kokuqala kanye naphansi kwetheyiphu yangaphansi. Okulandelayo, zohlobo ngalunye lwetheyiphu, sidale t-Imephu ekhombisa ukungasebenzi kahle emaqenjini eziguli ngokuqhathanisa iqembu ngalinye lesiguli ngokulawula kwalo, kukhiqiza i-PG-CPG kanye ne-CD-CCD umehluko. Ukuqhathanisa okwenziwe ngamakhompiyutha emikhondweni yokubaluleka elandelanayo (p<0.005, p<0.01, p<0.02 futhi p<0.05) zenzelwe ukukhomba izifunda lapho i-PG – CPG kanye ne-CD-CCD Ukuqhathanisa kubonise ukutholwa okufanayo. Iqembu ngalinye p-Maps kwasetshenziswa ukubona izifunda zobuchopho ezineqhaza kulokhu okutholakele. Azikho izifunda zobuchopho ezihlonziwe zisebenzisa le nqubo yokulutha, amakhomputha ajabule futhi adabukisayo. Njengoba izifundo zethu zangaphambili zikhombisile ukuthi isikhathi sokuqala sokubuka i-tepi, ngaphambi kokuqala kokuphendula okushukumisayo / kwemizwa, kuhlotshaniswa nokwehlukana okukhulu phakathi kweqembu izimpendulo kuma-videotapes omlutha (Wexler et al. 2001; amandla et al. 2003b), senze ucwaningo olufanayo sigxile esikhathini sokuqala sokubuka kwetheyiphu kuqhathaniswa nesisekelo sangaphambi kwetheyiphu. Le nqubo ikhombe izifunda zobuchopho eziningi (ithebula le-1b; bona i-figure 1B kokuqukethwe kokungezelwa kwe-elekthronikhi) okubonisa izinguquko zomsebenzi ofanayo ekuqhathaniseni phakathi kwezihloko eziluthayo nezokulawula ngesikhathi sokubuka kwamateyipu umlutha ofanele, futhi akukho zifunda ezikhonjwe ngokuqhathaniswa ezibandakanya ompompi abadabukisayo noma abajabulayo (abangakhonjiswanga).

Izifunda zobuchopho ezikhonjwe njengokukhombisa amaphethini okusebenza okuvamile ezinqabeni zezihloko ezingamakhoboka omlutha zifaka izifunda ezinegalelo ekusetshenzisweni ngokomzwelo nokushukumisayo, ukuhlolwa komvuzo nokwenza izinqumo, ukuvimbela impendulo, kanye nomphumela ekwelapheni umlutha. Ezimweni eziningi, lezi zifunda zazenziwa ngezifundo zokulawula kepha hhayi eziluthayo. Ukusebenza okuncishisiwe okuncishiswe kakhulu kwe-ventral striatum kwaqapheleka ezifundweni ezingumlutha ngokuqhathaniswa nezifundo zokulawula, kuyahambisana nokutholakele kwimisebenzi ebandakanya ukucubungula imivuzo kumaqembu ezihloko ze-PG ne-CD (Ukubuyela emuva et al. 2005; Pearlson et al. 2007). Izakhi ze-ventral ze-cortex zangaphambili, ikakhulukazi i-cortex ye-orbitofrontal, zifakwe umthelela ekucutshungulweni kwemivuzo (Schultz et al. 2000; Knutson et al. 2003; McClure et al. 2004), futhi isifunda esilandelanayo sicatshangelwa ukuthi sizosebenza lapho kudingeka imininingwane eyengeziwe ukuqondisa izindlela zokuziphatha noma lapho ukwenza izinqumo kufaka ukucindezela kwezimpendulo ezivuzwe ngaphambilini (Elliott et al. 2000). Izifunda ezizayo ze-cortex ye-ventral prefrontal preortal, efana ne-gyrus ephansi yangaphambilini, nazo zibhekwa njengezibaluleke kakhulu ekuvinjelweni kokuphendula nokulawula okungafuneki (IChamberlain neSahakian 2007). Ezinye izifunda zobuchopho ezinamaphethini wokusebenzisa amandla ahlukanisa izihloko ezingamlutha nezingamlutha ocwaningweni lwamanje nazo zibe nomthelela ekulameni ukulawulwa kwethonya. Isibonelo, ku-Go / NoGo paradigm ebandakanya izifundo ezinempilo, i-insula, i-precuneus ne-posterior cingulate zavuselelwa ngenkathi kusetshenzwa ngephutha kanye ne-orbitofadal cortex ne-girus yolimi ngesikhathi sokuvinjelwa kokuphendula (I-Menon et al. 2001). Ukwenza kusebenze ngaphakathi kufaka isandla ezifisweni futhi kungathonya izinqubo zokwenza izinqumo ekuluthweni (UCraig 2002; Naqvi et al. 2007). Ukwehluleka kwezifundo eziluthayo ukwenza kusebenze lezi zifunda kusigaba sokuqala sokuphendula ezinkambeni ezisebenza njengezimbangi kungaba nomthelela ekuzibambeni kabi nasekusebenziseni izidakamizwa okulandelayo. Lokhu okutholakele kunemiphumela yomphumela wokwelashwa wabo bobabili i-PG kanye nokulutha kwezidakamizwa. Isibonelo, ukulimala kwe-insula kuhlotshaniswe nokuziphatha okungafaneleki kokubheja njengoba kufakazelwa ukwehluleka ukulungisa ukubheja maqondana nemikhawulo yokuwina, futhi-ke ukusebenza okungekuhle kungathinta ikakhulukazi i-PG (Clark et al. 2008). I-activation cingrate activation ngesikhathi sokubuka amakhasethi e-cocaine yayihlotshaniswa nemiphumela yokwelashwa ezifundweni ze-CD, nalabo abakwazi ukwenqatshelwa kokubonisa ukusebenza okwengeziwe kwale ndawo yobuchopho (izindleko et al. 2006). Ngakho-ke, yize le miphumela kufanele ibhekwe njengokunikezwa kuqala amasampula amancane eqembu ngalinye lezifundo, okutholakele kuhambelana nezincwadi ezinkulu ku-PG, umlutha wezidakamizwa, ukulawulwa kokuthinteka kanye nokuhlobana kwe-neural komphumela wokwelashwa wokulutha kwezidakamizwa. Uphenyo olwengeziwe olubandakanya amasampula amakhulu nangaphezulu ayadingeka ukuze uqinise futhi wandise lokhu okutholakele.

I-6. Iziphetho nezinkomba zesikhathi esizayo

Yize kunentuthuko enkulu eyenziwe ekuqondeni kwethu i-PG kule minyaka eyishumi edlule, izikhala ezinkulu zisala ekuqondeni kwethu ngale nkinga. Izifundo eziningi zebhayoloji kuze kube manje ziye zabandakanya amasampula amancane abesilisa noma abesilisa kuphela, okuphakamisa ukukhathazeka maqondana nokutholakele kokutholakele, ikakhulukazi kubantu besifazane. Ukwehluka kobulili ekuziphatheni kokugembula kuye kwabikwa zombili maqondana nezinhlobo zezinkinga zokugembula kwabesifazane uma kuqhathaniswa nabesilisa kanye namaphethini wokuthuthuka kwezinkinga zokugembula (amandla et al. 2001). Isibonelo, into ye- 'telescoping', inqubo ebhekisele kusikhathi esinqunyelwe ngaphambili phakathi kokuqalisa namazinga ayinkinga wokuzibandakanya kokuziphatha, sichazwe okokuqala ngotshwala, muva nje nge-DD, futhi muva nje ngenkinga ne-PG (amandla et al. 2001). Uma kunikezwe umehluko ofanele emtholampilo, izivivinyo ku-biology eyisisekelo ye-PG kufanele zicabangele ukuthonya okungaba khona ocansini. Ngokufanayo, izigaba ezahlukahlukene zokugembula kwezokugembula kufanele zibhekwe ophenyweni lwebhayoloji, uma kunikezwe imininingwane eveza ukubandakanyeka okuhlukile kwe-neurocircuitry (isb. I -ralral volus dorsal striatum) njengoba izimilo zithuthuka zisuka kunoveli noma ngokuphoqelela kokuya ejwayelekile noma okuphoqayo (I-Everitt neRobbins 2005; Chambers et al. 2007; IBelin ne-Everitt 2008; IBrewer & Potenza 2008). Ukucatshangelwa okungeziwe kufaka uhlobo lokuphoqelela nobudlelwano bayo nama-ICD kanye nokuluthwa kwezidakamizwa. Okusho ukuthi, kungenzeka ukuthi ukusetshenziswa kwezidakamizwa kungaholela ekugembeni okuningi, ukugembula okwengeziwe kungaholela ekusetshenzisweni kwezidakamizwa, noma ukuthi izici ezivamile njengokuphoqelela zingaholela ekuzibandakanyeni ngokweqile kwesizinda ngasinye. Ukucacisa la mathuba kuzilungiselelo zezilwane nezezifiso zangempela kumelela umgomo ofanele ngokomtholampilo nangokwesayensi (Dalley et al. 2007). Ngokunikezwe ukuthi ukufakwa kungumakhi oyinkimbinkimbi owakhiwe (Moeller et al. 2001), ukuqonda ukuthi izici ezithile zihlobana kanjani nama-pathophysiologies kanye nokwelashwa kwe-PG nokulutha kwezidakamizwa kubalulekile. Okokugcina, i-PG ngokungenakuphikwa ifundwe kahle kunazo zonke zeqembu lama-ICD okwamanje ahlukaniswe ndawonye ezincwadini zokuhlonza. Ucwaningo olwengeziwe luyadingeka kwamanye ama-ICD kanye ne-neurobiology yawo, ukuvikela kanye nokwelashwa, ikakhulukazi njengoba lokhu kuphazamiseka kuhlotshaniswa nokumaka kakhulu i-psychopathology enkulu futhi kubonakale okwamanje ukuthi akuvunyelwa kuzilungiselelo zokwelashwa (Grant et al. 2005).

Ukuvuma

UBruce Wexler noCheryl Lacadie banikeze usizo ngomsebenzi wokuqagela amandla kazibuthe owethulwayo. Kusekelwa ngokwengxenye: , P01-AA019039), kanye neNational Center for Research Resources (UL01-RR020908); (ii) Ucwaningo Lwezempilo Labesifazane eYale; (iii) Ihhovisi Lezocwaningo Ngezempilo Yabesifazane kanye (iv) noMnyango Wezindaba Zase-US VISN50 MIRECC no-REAP.

wokudalula. UDkt Potenza ubika ukuthi akanakho ukungqubuzana kwezintshisakalo eminyakeni emithathu edlule ukubika njengokuhlobene nendaba yombiko. UDkt Potenza uthole ukwesekwa kwezezimali noma isinxephezelo ngalokhu okulandelayo: UDkt Potenza ubonisana futhi ungumeluleki weBoehringer Ingelheim; ubonisene futhi unentshisekelo yezezimali eSomaxon; uthole ukwesekwa kocwaningo kuNational Institutes of Health, Veteran's Administration, Mohegan Sun, and Forest Laboratories, Ortho-McNeil kanye ne-Oy-Control / Biotie pharmaceuticals; ubambe iqhaza ocwaningweni, ekuthumeleni noma ekubonisaneni ngocingo okuhlobene nokulutha kwezidakamizwa, ama-ICD noma ezinye izihloko zezempilo; ubonisé amahhovisi ezomthetho kanye neHhovisi Lomvikeli Womphakathi Wombuso ezindabeni eziphathelene nama-ICD; yenze ukubuyekezwa kwesibonelelo samaNational Institutes of Health namanye ama-ejensi; unikeze izinkulumo zezifundo emizuliswaneni emikhulu, Imicimbi Eqhubekayo Yezemfundo Yezokwelapha nakwezinye izindawo zemitholampilo noma zesayensi; kukhiqize izincwadi noma izahluko zezincwadi zabashicileli bemibhalo yezempilo yengqondo; futhi inikeza ukunakekelwa kwemitholampilo eMnyangweni Wezempilo Yengqondo Nezinsizakalo Zokulutha Izinkinga Zokugembula.

Imibhalo yaphansi

Umnikelo owodwa we-17 ku-Umhlangano Wengxoxo 'I-neurobiology yokulutha: i-vistas entsha'.

Izinto ezengeziwe

Umfanekiso we-1A:

Umfanekiso we-1B:

Inganekwane yomfanekiso:

Okubhekwayo

  • I-American Psychiatric Association. I-American Psychiatric Association; IWashington, DC: 1980. Iseluleko sokuxilonga nesibalo sokuphazamiseka kwengqondo.
  • I-Arnsten AF Fundamentals of ukunakwa-ukunakekelwa / ukuphazamiseka kwe-hyperactivity: amasekethe nezindlela. J. Clin. Ukusebenza kwengqondo. I-2006;67(I-Suppl. 8): 7-12. [I-PubMed]
  • I-Bechara A. Ibhizinisi eliyingozi: imizwelo, ukwenza izinqumo, nokulutha. J. Gambl. Isifundo. I-2003;19: 23-51. doi: 10.1023 / A: 1021223113233 [I-PubMed]
  • I-Belin D, i-Everitt BJ Cocaine yokufuna imikhuba incike ekuxhumekeni kwe-dopamine-kuncike kokuxhumana kwe-serial okuxhumanisa i-ventral ne-dorsal striatum. I-Neuron. I-2008;57: 432-441. i-doi: 10.1016 / j.neuron.2007.12.019 [I-PubMed]
  • I-Bergh C, i-Eklund T, iSodersten P, uNordin C. Ushintshe umsebenzi we-dopamine ekugembeni kwe-pathological. Psychol. UMedi. I-1997;27: 473-475. doi: 10.1017 / S0033291796003789 [I-PubMed]
  • Bjork JM, Knutson B, Fong GW, Caggiano DM, Bennett SM, Hommer DW Incentive-elicised activation ubuchopho entsheni: ukufana nomehluko ovela kubantu abadala abancane. J. Neurosci. I-2004;24: 1793-1802. i-doi: 10.1523 / JNEUROSCI.4862-03.2004 [I-PubMed]
  • UBlanco C, uPetkova E, u-Ibanez A, uSaiz-Ruiz J. Ucwaningo olulawulwa yi-fluboxamine lokugembula lwendiza. U-Ann. Clin. Ukusebenza kwengqondo. I-2002;14: 9-15. [I-PubMed]
  • Blumberg HP, et al. Ucwaningo olusebenzayo lokuhlaziya amandla kagesi olusebenza ngokuguquguquka kwe-bipolar disorder: ukungasebenzi kahle kwesimo kanye nomkhondo kuma-cortices e-ventral prefrontal. I-Arch. Gen. Psychiatry. I-2003;60: 601-609. doi: 10.1001 / archpsyc.60.6.601 [I-PubMed]
  • IBreaker HC, i-Rauch SL Umsebenzi we-MRI kanye nokufundwa kwe-OCD: kusuka ekubonakalisweni kwesibonakaliso kuya ekuqondisweni kokuziphatha kwezinhlelo ze-cortico-striatal system kanye ne-amygdala. I-Neuroimage. I-1996;4: S127-S138. doi: 10.1006 / nimg.1996.0063 [I-PubMed]
  • I-Brewer JA, i-Potenza MN I-neurobiology kanye ne-genetics of control impulse control ukuphazamiseka: ubudlelwane nemilutha yezidakamizwa. I-Biochem. I-Pharmacol. I-2008;75: 63-75. doi: 10.1016 / j.bcp.2007.06.043 [Isihloko samahhala se-PMC] [I-PubMed]
  • Brewer JA, Grant JE, Potenza MN Ukwelashwa kokugembula kwe-pathological. Umlutha We-Disord. Phatha. I-2008;7: 1-14. doi:10.1097/ADT.0b013e31803155c2
  • I-Bush GW, i-Luu P, i-Posner MI nethonya lemizwa ngokomzwelo ku-cortex ye-anterior. Ukuziphatha Kwemikhuba. Isayensi I-2000;4: 215-222. doi:10.1016/S1364-6613(00)01483-2 [I-PubMed]
  • IChamberlain SR, iSahakian BJ I-neuropsychiatry yokuxoshwa. UCrr. Opin. Ukusebenza kwengqondo. I-2007;20: 255-261. [I-PubMed]
  • IChambers RA, Taylor JR, Potenza MN Developmental neurocircuitry yesisusa ebusheni: isikhathi esibucayi sokulimazeka kokulutha. Am. J. Psychiatry. I-2003;160: 1041-1052. i-doi: 10.1176 / appi.ajp.160.6.1041 [Isihloko samahhala se-PMC] [I-PubMed]
  • IChambers RA, i-Bickel WK, i-Potenza MN Uhlelo olungelona olwe-theory lwesisusa kanye nomlutha. I-Neurosci. I-Biobehav. IsAm. I-2007;31: 1017-1045. doi: 10.1016 / j.neubiorev.2007.04.005 [Isihloko samahhala se-PMC] [I-PubMed]
  • I-Childress AR, i-Mozely PD, i-McElgin W, i-Fitzgerald J, i-Reivich M, i-O'Brien CP ye-Limbic isebenze ngesikhathi sokulangazelela i-cocaine. Am. J. Psychiatry. I-1999;156: 11-18. [Isihloko samahhala se-PMC] [I-PubMed]
  • UClark, L., Bechara, A., Damasio, H., Aitken, MRF, Sahakian, BJ & Robbins, TW 2008 Imiphumela eyahlukile yezilonda zangaphakathi nezangaphakathi ze-cortex ekuthathweni kwezinqumo okuyingozi. Brain131, 1311-1322. (doi: 10.1093 / ubuchopho / awn066) [Isihloko samahhala se-PMC] [I-PubMed]
  • Comings DE I-genetics yamangqamuzana okugembula kwe-pathological. I-CNS Spectr. I-1998;3: 20-37.
  • I-Coric V, iKelmendi B, iPittenger C, i-Wasylink S, i-Bloch MH Imiphumela emihle ye-antiglutamatergic agent riluzole esigulini okutholakale ukuthi sinayo i-trichotillomania. J. Clin. Ukusebenza kwengqondo. I-2007;68: 170-171. [I-PubMed]
  • Craig AD Uzizwa unjani? Ukuqonda: umqondo wesimo somzimba womzimba. Nat. UMfundisi Neurosci. I-2002;3: 655-666. i-doi: 10.1038 / nrn894 [I-PubMed]
  • UCrockford DN, uGoodyear B, u-Edward J, u-Quickfall J, u-Gu-Guabely N. uCue-owenze umsebenzi wobuchopho kubagembuli be-pathological. Biol. Ukusebenza kwengqondo. I-2005;58: 787-795. i-doi: 10.1016 / j.biopsych.2005.04.037 [I-PubMed]
  • UDalley JW, et al. Ama-receptors ama-Nucleus D2 / 3 receptors trait impulsivity kanye nokuqiniswa kwe-cocaine. Isayensi. I-2007;315: 1267-1270. i-doi: 10.1126 / isayensi.1137073 [Isihloko samahhala se-PMC] [I-PubMed]
  • da Silva Lobo DS, Vallada HP, Knight J, Martins SS, Tavares H, Gentil V, uKennedy JL Dopamine ufuzo nokugembula kwe-pathological kuma-single-pairs. J. Gambl. Isifundo. I-2007;23: 421-433. i-doi: 10.1007 / s10899-007-9060-x [I-PubMed]
  • I-DeCaria CM, Begaz T, Hollander E. Serotonergic kanye ne-noradrenergic emsebenzini wokugembula kwe-pathological. I-CNS Spectr. I-1998;3: 38-47.
  • I-Elliott R, i-Dolan RJ, imisebenzi ye-Frith CD Dissociable ku-cortex ye-medial kanye ne-orbitofrontal cortex: ubufakazi obuvela ezifundweni zabantu ze-neuroimaging. UCerebi. Cortex. I-2000;10: 308-317. doi: 10.1093 / cercor / 10.3.308 [I-PubMed]
  • U-Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ Factors onomthelela ekucindezelekeni kokuphoqelela ukusetshenziswa kwezidakamizwa kwe-dopaminergic kwisifo saseParkinson. I-Neurology. I-2005;65: 1570-1574. doi: 10.1212 / 01.wnl.0000184487.72289.f0 [I-PubMed]
  • I-everitt B, izinhlelo ze-Robbins TW Neural zokuqinisa umlutha wezidakamizwa: kusuka ezenzweni kuya imikhuba ukuya ekuphoqelweni. Nat. I-Neurosci. I-2005;8: 1481-1489. i-doi: 10.1038 / nn1579 [I-PubMed]
  • UFebo M, uSegarra AC, uNair G, uSchmidt K, uDuong TK, uFerris CF Imiphumela emibi yokuvezwa okuphindwe kabili kwe-cocaine eyembulwa yi-MRI esebenza kahle kumagundane aphapheme. I-Neuropsychopharmacology. I-2005;30: 936-943. i-doi: 10.1038 / sj.npp.1300653 [Isihloko samahhala se-PMC] [I-PubMed]
  • UFriston KJ, Worsleym KJ, Frackowiak RSJ, Mazziotta JC, u-Evans AC Ukuhlola ukubaluleka kokusebenza okugxile kusetshenziswa indawo yabo yendawo. I-Hum. I-Brain Mapp. I-1994;1: 214-220. doi: 10.1002 / hbm.460010207
  • UGaravan H, Hester R, Murphy K, Fassbender C, Kelly C. Ukungafani komuntu ngamunye ku-anatomy esebenzayo yokulawula inhibitory. I-Brain Res. I-2006;1105: 130-142. i-doi: 10.1016 / j.brainres.2006.03.029 [I-PubMed]
  • UGiovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJL Hedonic homeostatic dysregulation ezigulini ezinesifo sikaParkinson's on dopamine replacement therapies. J. Neurol. Neurosurg. Psychiatr. I-2000;68: 423-428. i-doi: 10.1136 / jnnp.68.4.423 [Isihloko samahhala se-PMC] [I-PubMed]
  • I-Goldstein RZ, Tomasi D, Rajaram S, Cottone LA, Zhang L, Maloney T, Telang F, Alia-Klein N, Volkow ND Indima ye-cterxe yangaphandle kanye ne-medial orbitofrontal cortex ekuqhubeni izinkomba zezidakamizwa ekuluthweni kwecocaine. I-neuroscience. I-2007;144: 1153-1159. doi: 10.1016 / j.neuroscience.2006.11.024 [Isihloko samahhala se-PMC] [I-PubMed]
  • U-Goudriaan AE, u-Oosterlaan J, de Beurs E, van den Brink W. Ukugembula okuphathelene nemigwaqo: isibuyekezo esigcwele sokutholakele kokutholwe ngumuntu ophilayo. I-Neurosci. I-Biobehav. IsAm. I-2004;28: 123-141. doi: 10.1016 / j.neubiorev.2004.03.001 [I-PubMed]
  • Grant JE, Potenza MN Escitalopram ukwelashwa kokugembula kwe-pathological nokukhathazeka okwenzeka ngokubambisana: isifundo somshayeli wendiza esivulekile ngokunqanyulwa okungaboni okubili. Int. Clin. I-Psychopharmacol. I-2006;21: 203-209. i-doi: 10.1097 / 00004850-200607000-00002 [I-PubMed]
  • UGrant JE, uKim SW, uPotenza MN, uBlanco C, u-Ibanez A, uStevens LC, uZaninelli R. Paroxetine ukwelashwa ngokugembula kwe-pathological: isivivinyo esilawulwa ngokungaxhunyiwe esikhungweni esiphakathi nendawo. Int. Clin. I-Psychopharmacol. I-2003;18: 243-249. i-doi: 10.1097 / 00004850-200307000-00007 [I-PubMed]
  • UGrant JE, uLevine L, uKim D, uPotenza MN Impulse control ukuphazamiseka kwezifo zezengqondo zabantu abadala. Am. J. Psychiatry. I-2005;162: 2184-2188. i-doi: 10.1176 / appi.ajp.162.11.2184 [I-PubMed]
  • UGrant JE, uPotenza MN, uHollander E, uCunningham-Williams RM, uNuminen T, uSmits G, uKallio A. Uphenyo oluningi ngokuphathwa kwe-opioid antagonist nalmefene ekwelapheni ukugembula kwe-pathological. Am. J. Psychiatry. I-2006;163: 303-312. i-doi: 10.1176 / appi.ajp.163.2.303 [I-PubMed]
  • UGrant JE, uKim SW, u-Odlaug BL NI--acetyl cysteine, i-ejut-glulamate-modulating agent ekwelapheni ukugembula kwe-pathological: isifundo somshayeli wendiza. Biol. Ukusebenza kwengqondo. I-2007;62: 652-657. i-doi: 10.1016 / j.biopsych.2006.11.021 [I-PubMed]
  • UGrant, JE, Kim, SW, Hollander, E. & Potenza, MN 2008 Ukubikezela ukuphendula kwabamelene ne-opiate kanye ne-placebo ekwelapheni ukugembula kwezifo. I-Psychopharmacology (doi:10.1007/s00213-008-1235-3) [I-PubMed]
  • Harvey JA Cocaine imiphumela ebuchosheni obukhulayo. I-Neurosci. I-Biobehav. IsAm. I-2004;27: 751-764. doi: 10.1016 / j.neubiorev.2003.11.006 [I-PubMed]
  • IHollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. Icala lokuphamba ngokungakhethi le-blind-fluvoxamine / placebo ngokungakhethi emgomeni wokugembula. Biol. Ukusebenza kwengqondo. I-2000;47: 813-817. doi:10.1016/S0006-3223(00)00241-9 [I-PubMed]
  • IHollander E, Pallanti S, Rossi NB, Sood E, Baker BR, Buchsbaum MS Imfire umvuzo wemali kwababhejayo be-pathological. UMhlaba J. Biol. Ukusebenza kwengqondo. I-2005;6: 113-120. i-doi: 10.1080 / 15622970510029768 [I-PubMed]
  • Hommer, D. 2004 Motivation ku-uphuzo oludakayo. In Int. Conf. kwizicelo ze-Neuroimaging to Alcoholism, New Haven, CT.
  • Hommer D, Andreasen P, Rio D, Williams W, Rettimann U, Monenan R, Zametkin A, Rawlings R, Linnoila M. Imiphumela ye m-chlorophenylpiperazine ekusetshenzisweni kweglucose yobuchopho kwesifunda: ukuqhathanisa kwe-positron kususa kwe-posographic kwezihloko ezinotshwala nezokulawula. J. Neurosci. I-1997;17: 2796-2806. [I-PubMed]
  • UHommer DW, Bjork JM, Knutson B, Caggiano D, Fong G, Danube C. Motivation ezinganeni zezidakwa. Utshwala. Clin. Khipha. Res. I-2004;28: I-22A. i-doi: 10.1097 / 00000374-200408002-00412
  • UJellinger KA Pathology wesifo sikaParkinson: i-pathology ngaphandle kwendlela ye-nigrostriatal. Mol. Amakhemikhali. Neuropathol. I-1991;14: 153-197. [I-PubMed]
  • I-Kalivas PW, iVolkow ND Isisekelo se-neural sokulutha: i-pathology ye-motivation kanye nokuzikhethela. Am. J. Psychiatry. I-2005;162: 1403-1413. i-doi: 10.1176 / appi.ajp.162.8.1403 [I-PubMed]
  • UKim SW, uGrant JE, u-Adson DE, uShin YC ophinde abe ngu-naltrexone ophindwe kabili ongaboni kanye nesifundo sokuqhathanisa se-placebo ekwelapheni ukugembula kwe-pathological. Biol. Ukusebenza kwengqondo. I-2001;49: 914-921. doi:10.1016/S0006-3223(01)01079-4 [I-PubMed]
  • UKim SW, uGrant JE, u-Adson DE, uShin YC, uZaninelli R. Ucwaningo olugxiliwe oluphindwe kabili, olawulwa nge-placebo ngempumelelo nokuphepha kwe-paroxetine ekwelapheni ukuphazamiseka kokugembula kwe-pathological. J. Clin. Ukusebenza kwengqondo. I-2002;63: 501-507. [I-PubMed]
  • I-Knutson B, i-Fong GW, i-Bennett SM, i-Adams CM, i-Hommer D. Isifunda samathrekhi ase-cortex athola phambili ngemiphumela emihle evuza imali: ukubonwa nge-fMRI ehlobene nomcimbi. I-Neuroimage. I-2003;18: 263-272. doi:10.1016/S1053-8119(02)00057-5 [I-PubMed]
  • I-Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE Cue-ikiwa umsebenzi wezinguquko zobuchopho futhi ubuyela kwiziguli ezincike ku-cocaine. I-Neuropsychopharmacology. I-2006;31: 644-650. i-doi: 10.1038 / sj.npp.1300851 [I-PubMed]
  • I-Lang AE, Izinselelo ze-Obeso JA kwisifo sikaParkinson: ukubuyiselwa kohlelo lwe-nigrostriatal dopamine alwanele. I-Lancet Neurol. I-2004;3: 309-316. doi:10.1016/S1474-4422(04)00740-9 [I-PubMed]
  • U-Linnoila M, uVirkunnen M, uScheinen M, uNuutila A, uRimon R, uGoodwin F. Umuthi ophansi we-cerebrospinal 5 hydroxy indolacetic acid ugxila ngokungafani nokuziphatha okungahambisani nobudlova. Life Sci. I-1983;33: 2609-2614. doi:10.1016/0024-3205(83)90344-2 [I-PubMed]
  • UMamikonyan E, uSiderowf AD, uDuda JE, uPotenza MN, uHorn S, uStern MB, uWeintraub D. Ukulandelwa kwesikhathi eside kokuphazamiseka kokulawula umfutho esifo sikaParkinson. I-Mov. I-Disord. I-2008;23: 75-80. doi: 10.1002 / mds.21770 [Isihloko samahhala se-PMC] [I-PubMed]
  • UMcClure S, uLaibson DI, uLoewenstein G, uCohen JD Izinhlelo ezingafani ze-neural zibonisa imivuzo yemali esheshayo neyephuzayo. Isayensi. I-2004;306: 503-507. i-doi: 10.1126 / isayensi.1100907 [I-PubMed]
  • I-Menon V, i-Adleman NE, iCD emhlophe, iGlover GH, ukuvulwa kobuchopho okuhlobene nephutha i-Reiss AL ngesikhathi somsebenzi wokuvinjwa kokuphendula we-Go / NoGo. I-Hum. I-Brain Mapp. I-2001;12: 131-143. doi:10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C [I-PubMed]
  • Meyer G, Hauffa BP, schedulelowski M, Pawluk C, Stadler MA, Exton MS Casino ukugembula kukhuphula izinga lokushaya kwenhliziyo kanye ne-salivary cortisol ekugembeni okuvamile. Biol. Ukusebenza kwengqondo. I-2000;48: 948-953. doi:10.1016/S0006-3223(00)00888-X [I-PubMed]
  • Meyer G, Schwertfeger J, Exton MS, Janssen OE, Knapp W, Stadler MA, schedulelowski M, Kruger TH Neuroendocrine ukuphendula ukugembula kwekhasino ezinkingeni zokugembula. I-Psychoneuroendocrinology. I-2004;29: 1272-1280. doi: 10.1016 / j.psyneuen.2004.03.005 [I-PubMed]
  • Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC Psychiatric factor of impulsivity. Am. J. Psychiatry. I-2001;158: 1783-1793. i-doi: 10.1176 / appi.ajp.158.11.1783 [I-PubMed]
  • UNaqvi NH, uRudrauf D, uDamasio H, uBechara A. Ukulimala endaweni yokufakelwa kuphazamisa umlutha wokubhema ugwayi. Isayensi. I-2007;5811: 531-534. i-doi: 10.1126 / isayensi.1135926 [I-PubMed]
  • Izindlela ze-Nestler EJ zamangqamuzana omlutha wezidakamizwa. I-Neuropharmacology. I-2004;47: 24-32. i-doi: 10.1016 / j.neuropharm.2004.06.031 [I-PubMed]
  • New AS, et al. Impendulo ye-tomation yokuqala yangaphambi kwecortical ye-18-fluorodeoxyglucose efihliwe yangaphambilini meta-chlorophenylpiperazine ulaka olungenakuphikiswa. I-Arch. Gen. Psychiatry. I-2002;59: 621-629. doi: 10.1001 / archpsyc.59.7.621 [I-PubMed]
  • UNordin C, Eklundh T. Oshintshiwe we-CSF 5-HIAA ekulahlekelweni kwabesilisa ngokugembula. I-CNS Spectr. I-1999;4: 25-33. [I-PubMed]
  • U-Oslin DW, Berrettini W, Kranzler HR, Pettinate H, Gelernter J, Volpicelli JR, O'Brien CP I-polymorphism esebenzayo yohlobo lwe-mu-opioid receptor ihlotshaniswa nempendulo ye-naltrexone ezigulini ezincike otshwaleni. I-Neuropsychophamacology. I-2003;28: 1546-1552. i-doi: 10.1038 / sj.npp.1300219 [I-PubMed]
  • UPallanti S, Bernardi S, Quercioli L, DeCaria C, uHollander E. Serotonin ukungasebenzi kahle kwabadlali bokugembula abasebenza ngokungemthetho: ukukhuphuka kokuphendula kwe-prolactin ku-m-CPP yomlomo eqhathaniswa ne-placebo. I-CNS Spectr. I-2006;11: 955-964. [I-PubMed]
  • UPearlson, GD, Shashwath, M., Andre, T., Hylton, J., Potenza, MN, Worhunsky, P., Andrews, M. & Stevens, M. 2007 Ukusebenza okungajwayelekile kwe-fMRI kokujikeleza komvuzo kulaba abahlukumeza abakhona manje . Ku- I-American College of Neuropsychopharmacology Ingqungquthela Yonyaka, Boca Raton, FL.
  • UPetry NM, uStinson FS, Grant BF Co-morbidity we-DSM-IV ukugembula kwe-pathological kanye nezinye izifo zengqondo: imiphumela evela ku-National Epidemiologic Survey mayelana Notshwala Nezimo Ezihlobene Nazo. J. Clin. Ukusebenza kwengqondo. I-2005;66: 564-574. [I-PubMed]
  • I-Potenza MN Kufanele ngabe ukuphazamiseka okuluthayo kufaka phakathi izimo ezingahambelani nezidakamizwa? Umlutha. I-2006;101(I-Suppl. 1): 142-151. i-doi: 10.1111 / j.1360-0443.2006.01591.x [I-PubMed]
  • UPotenza MN, uSteinberg MA, uMcLaughlin S, uWu R, uRounsaville BJ, u-O'Malley SS umehluko ohlobene nobulili kuzimpawu zabanenkinga yokugembula abasebenzisa ucingo losizo lokugembula. Am. J. Psychiatry. I-2001;158: 1500-1505. i-doi: 10.1176 / appi.ajp.158.9.1500 [I-PubMed]
  • UPotenza MN, uLeung H.-C, uBlumberg HP, uPeterson BS, uSkudlarski P, uLacadie C, uLore JC Ucwaningo lwe-fMRI Stroop lomsebenzi we-cortical we-ventromedial prefrontal preortal cortical in gological. Am. J. Psychiatry. 2003a;160: 1990-1994. i-doi: 10.1176 / appi.ajp.160.11.1990 [I-PubMed]
  • UPotenza MN, uSteinberg MA, uSkudlarski P, uFulbright RK, uLacadie C, uWilber MK, uRounsaville BJ, u-Gore JC, u-Wexler BE Gambela ukunxenxa kubagembuli be-pathological: isifundo se-fMRI. I-Arch. Gen. Psychiatry. I-2003b;60: 828-836. doi: 10.1001 / archpsyc.60.8.828 [I-PubMed]
  • I-Potenza MN, i-Voon V, i-Weintraub D. Ukuqonda izidakamizwa: ukuphazamiseka kokulawula umfutho kanye nokwelashwa kwe-dopamine kwisifo sikaParkinson. Nat. Clin. Prakthiza. I-Neurosci. I-2007;3: 664-672. doi: 10.1038 / ncpneuro0680 [I-PubMed]
  • Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C. Ukugembula kokuthinteka kuhlobene nokuncishiswa kokuncishiswa kohlelo lwemvuzo lwe-mesolimbic. Nat. I-Neurosci. I-2005;8: 147-148. i-doi: 10.1038 / nn1378 [I-PubMed]
  • URoy A, et al. Ukugembula kwe-pathological. Isifundo se-psychobiological. I-Arch. Gen. Psychiatry. I-1988;45: 369-373. [I-PubMed]
  • URoy A, de Jong J, uLinnoila M. Ukungezelela kokugembula okuphathelene ne-pathological: izixhumanisi ezihambelana nezinkomba zomsebenzi we-noradrenergic. I-Arch. Gen. Psychiatry. I-1989;46: 679-681. [I-PubMed]
  • Schultz W, Tremblay L, Hollerman JR Reward process in prort orbitofrontal cortex and basal ganglia. UCerebi. Cortex. I-2000;10: 272-284. doi: 10.1093 / cercor / 10.3.272 [I-PubMed]
  • UShaffer HJ, uKorn DA Ukugembula kanye nokuphazamiseka kwengqondo okuhlobene nakho: ukuhlaziywa kwezempilo yomphakathi. Annu. IsAm Health Health. I-2002;23: 171-212. i-doi: 10.1146 / annurev.publhealth.23.100901.140532 [I-PubMed]
  • UShaffer HJ, Hall MN, uVander Bilt J. Ukulinganisa ukwanda kokugembula okukhohlakele e-United States naseCanada: uhlobo lokucwaninga. Am. J. Ezempilo Yomphakathi. I-1999;89: 1369-1376. [Isihloko samahhala se-PMC] [I-PubMed]
  • UShinohara K, uYanagisawa A, uKagota Y, Gomi A, uNemoto K, uMoriya E, uFurusawa E, uFuruya K, uTersawa K. Izinguquko zomzimba kubadlali bePachinko; i-beta-endorphin, i-catecholamines, izinto zomzimba wokuzivikela kanye nesilinganiso senhliziyo. I-Appl. Isayensi Yabantu. I-1999;18: 37-42. doi: 10.2114 / jpa.18.37 [I-PubMed]
  • Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA, Sevin E, Nunn M, Mitropoulou V. d,lImpendulo ye -Fenfluaramine ekuxinaniseni ubuntu bokuxineka okuhlolwe nge [18F] i-fluorodeoxyglucose positron emission tomography. I-Neuropsychopharmacology. I-1999;20: 413-423. doi:10.1016/S0893-133X(98)00111-0 [I-PubMed]
  • I-Spanagel R, Herz A, iSeppenberg TS Ukuphikisana nezinhlelo ze-opioid ezisebenzayo ze-opioid ziguqula indlela ye-mesolimbic dopaminergic. I-Proc. Natl Acad. Isayensi E-USA. I-1992;89: 2046-2050. i-doi: 10.1073 / pnas.89.6.2046 [Isihloko samahhala se-PMC] [I-PubMed]
  • UTanabe J, Thompson L, uClaus E, uDalwani M, uHutchison K, umsebenzi weBortich Precental cortex uyancipha ekugembeni nakwabasebenzisa izidakamizwa ze-nongurb ngesikhathi sokuthatha izinqumo. I-Hum. I-Brain Mapp. I-2007;28: 1276-1286. doi: 10.1002 / hbm.20344 [I-PubMed]
  • UVoon V, uHassan K, uZurowski M, de Souza M, uThomsen T, uFox S, uLang AE, uMiyasaki J. Ukudlanga kokuziphatha okuphindaphindayo nokufuna umvuzo kusifo sikaParkinson. I-Neurology. I-2006;67: 1254-1257. i-doi: 10.1212 / 01.wnl.0000238503.20816.13 [I-PubMed]
  • IVoon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M. Izinto ezihlotshaniswa nokugembula okuhlobene nezidakamizwa okuhlobene nezidakamizwa ku-dopaminergic. I-Arch. INeurol. I-2007;64: 212-216. i-doi: 10.1001 / i-archneur.64.2.212 [I-PubMed]
  • I-Weintraub D, i-Siderow A, i-Potenza MN, i-Goveas J, i-Morales K, i-Duda J, i-Moberg P, i-Stern M. Dopamine ukusetshenziswa kwe-agonist kuhlotshaniswa nokuphazamiseka kokulawula umfutho kwisifo sika-Parkinson. I-Arch. INeurol. I-2006;63: 969-973. i-doi: 10.1001 / i-archneur.63.7.969 [Isihloko samahhala se-PMC] [I-PubMed]
  • Wexler BE, Gottschalk CH, Fulbright RK, Prohovnik I, Lacadie CM, Rounsaville BJ, Gore JC Umsebenzi osebenza ngozibuthe oshukumisayo wokufuna i-cocaine. Am. J. Psychiatry. I-2001;158: 86-95. i-doi: 10.1176 / appi.ajp.158.1.86 [I-PubMed]
  • Ubhale uJ, et al. Ukungasebenzi kokulungiswa kwemivuzo kuhambelana nokunxanelwa kotshwala kwizidakwa eziphuhlisiwe. I-Neuroimage. I-2007;35: 787-794. doi: 10.1016 / j.neuroimage.2006.11.043 [I-PubMed]